Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors
Authors:ID Mikolič, Veronika (Author)
ID Pantović, Jelica (Author)
ID Malenšek, Špela (Author)
ID Sever, Matjaž (Author)
ID Lainšček, Duško (Author)
ID Jerala, Roman (Author)
Files:.pdf PDF - Presentation file, download (4,10 MB)
MD5: 162F08C562E04E2133DB5BE9FB4B34B1
 
URL URL - Source URL, visit https://www.sciencedirect.com/science/article/pii/S2950329924000572
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 1-14
Numbering:Vol. 32, [article no.] 200815
PID:20.500.12556/DiRROS-30064 New window
UDC:577
ISSN on article:2950-3299
DOI:10.1016/j.omton.2024.200815 New window
COBISS.SI-ID:197865987 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 5. 6. 2024;
Publication date in DiRROS:12.06.2026
Views:36
Downloads:17
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Molecular therapy : oncology
Publisher:Elsevier
ISSN:2950-3299
COBISS.SI-ID:197861635 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0176-2022
Name:Sintezna biologija in imunologija

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4640-2022
Name:Inovativna imunoterapija raka preko CAR T celic (CARRS)

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J4-4563-2022
Name:Uporaba izboljšanega sistema CRISPR/Cas za nevirusno produkcijo celic CAR-T

Funder:Other - Other funder or multiple funders
Project number:P3–0289
Name:Značilnosti malignih neoplazem, pomembne za diagnozo ter napoved poteka bolezni in izida zdravljenja

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:biokemija, antigen, receptorji, CAR, RNK, geni, tumorji, celice T


Back